Chemoinformaics analysis of Lupinisoflavone L
| Molecular Weight | 436.46 | nRot | 2 |
| Heavy Atom Molecular Weight | 412.268 | nRig | 27 |
| Exact Molecular Weight | 436.152 | nRing | 5 |
| Solubility: LogS | -2.989 | nHRing | 3 |
| Solubility: LogP | 5.139 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 63.367 |
| nHD | 3 | BPOL | 30.153 |
| QED | 0.554 |
| Synth | 3.884 |
| Natural Product Likeliness | 2.809 |
| NR-PPAR-gamma | 0.976 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.736 |
| Pgp-sub | 0.001 |
| HIA | 0.048 |
| CACO-2 | -4.793 |
| MDCK | 0.0000183 |
| BBB | 0.009 |
| PPB | 0.996106 |
| VDSS | 0.377 |
| FU | 0.0224239 |
| CYP1A2-inh | 0.281 |
| CYP1A2-sub | 0.406 |
| CYP2c19-inh | 0.24 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.717 |
| CYP2c9-sub | 0.881 |
| CYP2d6-inh | 0.654 |
| CYP2d6-sub | 0.337 |
| CYP3a4-inh | 0.332 |
| CYP3a4-sub | 0.211 |
| CL | 1.611 |
| T12 | 0.144 |
| hERG | 0.022 |
| Ames | 0.031 |
| ROA | 0.801 |
| SkinSen | 0.689 |
| Carcinogencity | 0.794 |
| EI | 0.046 |
| Respiratory | 0.184 |
| NR-Aromatase | 0.906 |
| Antiviral | Yes |
| Prediction | 0.744751 |